Closed-loop control of glucose according to a predicted blood glucose trajectory

An apparatus comprising:

• one or more infusion pumps to infuse a substance into a body in response to commands;
• and
• a controller to:
• predict a trajectory of a blood glucose level of said body based, at least in part, on past observations of said blood glucose level;
• determine a cost expression based, at least in part, on said predicted trajectory,
• wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,
• wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, and
• wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time;
• and
• affect at least one future command to said one or more infusion pumps so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period wherein the at least one future command controls the system operation according to said cost expression.

An article comprising:

• a non-transitory storage medium comprising machine-readable instructions executable by a special purpose computing apparatus to:
• predict a trajectory of a blood glucose level of the body based, at least in part, on past observations of said blood glucose level;
• determine a cost expression based, at least in part, on said predicted trajectory,
• wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,
• wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, and
• wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time;
• and
• affect at least one future command to one or more infusion pumps so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period according to said cost expression.

An apparatus comprising:

• a means for predicting a trajectory of a blood glucose level of a patient based, at least in part, on past observations of said blood glucose level;
• a means for determining a cost expression based, at least in part, on said predicted trajectory,
• wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,
• wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, and
• wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time;
• and
• a means for affecting at least one future command to at least one infusion pump to infuse a substance into the patient, and so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period according to said cost expression.